Wed Nov 23, 2022 – 8:36 pm EST
BETHESDA, Maryland (LifeSiteNews) — The Biden administration’s National Institutes of Health (NIH) this week gave a generic non-answer in response to Arizona Republican U.S. Rep. Paul Gosar’s October request that the agency explore the scientific research behind so-called “Gender Affirming Care” (GAC) for minors. GAC uses drugs and surgeries to make patients appear more like the opposite sex and can cause permanent physical and psychological damage.
In a form-letter style response sent a month after Rep. Gosar made the request, NIH acting director Dr. Lawrence A. Tabak, D.D.S., Ph.D. thanked the Republican for his “interest in this upcoming NIH-sponsored workshop” and assured him the agency “strives to foster fundamental creative discoveries, innovative research strategies, and their applications as a basis for ultimately protecting and improving health for all Americans, including transgender and gender-diverse populations.”
Continuing in broad terms, Tabak added that the NIH “encourages research across a variety of sexual and gender minority (SGM)-related topics, including how social and medical transition, along with behavioral factors, impact outcomes for gender-diverse populations.”
📣 @NIH‘s Sexual & Gender Minority Research Office (SGMRO) is seeking info on research opportunities for their
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors